The present invention provides new uses of DPIV-inhibitors of the present invention, and their corresponding pharmaceutically acceptable acid addition salt forms, for treating conditions mediated by DPIV or DPIV-like enzymes, such as cancer and tumors. In a more preferred embodiment, the compounds of the present invention are useful for the treatment of metastasis and tumor colonization.

 
Web www.patentalert.com

< Piperidine derivatives and agent comprising the derivative as active ingredient

< Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto

> Tocopherol enriched compositions and amelioration of inflammatory symptoms

> Highly purified ethyl EPA and other EPA derivatives for treatment of huntington's disease
~ 00287